Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
The New England Journal of Medicine
|
June 22, 2025
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes
Trevor W Reichman, James F Markmann, Jon Odorico, et al.
The Lancet. Diabetes & Endocrinology
|
January 28, 2017
Exercise management in type 1 diabetes: a consensus statement
Michael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Diabetes Care
|
September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Grazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Journal of Diabetes Science and Technology
|
November 9, 2024
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
Viral N Shah, Anne L Peters, Guillermo E Umpierrez, et al.
JAMA
|
June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Thomas Martens, Roy W Beck, Ryan Bailey, et al.
Diabetes Technology & Therapeutics
|
May 17, 2024
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens
Gregg D Simonson, Amy B Criego, Tadej Battelino, et al.
Journal of Diabetes Science and Technology
|
February 12, 2025
Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes
Nicole L Spartano, Brenton Prescott, Maura E Walker, et al.
Diabetes Care
|
December 19, 2015
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes
Ruth S Weinstock, Stephanie N DuBose, Richard M Bergenstal, et al.
JAMA Network Open
|
February 14, 2025
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial
Francisco J Pasquel, Georgia M Davis, David M Huffman, et al.
Diabetes Technology & Therapeutics
|
March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
Kellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
The New England Journal of Medicine
|
June 22, 2025
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes
Trevor W Reichman, James F Markmann, Jon Odorico, et al.
The Lancet. Diabetes & Endocrinology
|
January 28, 2017
Exercise management in type 1 diabetes: a consensus statement
Michael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Diabetes Care
|
September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Grazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Journal of Diabetes Science and Technology
|
November 9, 2024
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
Viral N Shah, Anne L Peters, Guillermo E Umpierrez, et al.
JAMA
|
June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Thomas Martens, Roy W Beck, Ryan Bailey, et al.
Diabetes Technology & Therapeutics
|
May 17, 2024
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens
Gregg D Simonson, Amy B Criego, Tadej Battelino, et al.
Journal of Diabetes Science and Technology
|
February 12, 2025
Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes
Nicole L Spartano, Brenton Prescott, Maura E Walker, et al.
Diabetes Care
|
December 19, 2015
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes
Ruth S Weinstock, Stephanie N DuBose, Richard M Bergenstal, et al.
JAMA Network Open
|
February 14, 2025
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial
Francisco J Pasquel, Georgia M Davis, David M Huffman, et al.
Diabetes Technology & Therapeutics
|
March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
Kellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Page
of 13